Glycemic variability:: A hemoglobin A1c-independent risk factor for diabetic complications

被引：357

作者：

Brownlee, M

Hirsch, IB

机构：

[1] Univ Washington, Sch Med, Diabet Care Ctr, Seattle, WA 98105 USA

[2] Albert Einstein Coll Med, JDRF Int Ctr Diabet Complicat Res, Bronx, NY 10467 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 14期

关键词：

D O I：

10.1001/jama.295.14.1707

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1707 / 1708

页数：2

共 21 条

[1] *AM COLL END, 2002, ENDOCR PRACT S1, V8, P5
[2] [Anonymous], 2005, DIABETES CARE, V28, pS4
[3] [Anonymous], 1995, DIABETES, V44, P968
[4] Biochemistry and molecular cell biology of diabetic complications
Brownlee, M
[J]. NATURE, 2001, 414 (6865) : 813 - 820
[5] The pathobiology of diabetic complications - A unifying mechanism
Brownlee, M
[J]. DIABETES, 2005, 54 (06) : 1615 - 1625
[6] Devaraj S, 2001, CLIN CHEM, V47, P1974
[7] Thromboxane, prostacyclin and isoprostanes:: therapeutic targets in atherogenesis
Dogné, JM
Hanson, J
Pratico, D
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (12) : 639 - 644
[8] DU X, 2006, J CLIN INVEST
[9] What does postprandial hyperglycaemia mean?
Heine, RJ
Balkau, B
Ceriello, A
Del Prato, S
Horton, ES
Taskinen, MR
[J]. DIABETIC MEDICINE, 2004, 21 (03) : 208 - 213
[10] Hirsch Irl B, 2004, Endocr Pract, V10, P67